Abstract
A TAT inhibitor (ro 24-7429): The single-dose study in humans : P.S. Lietman, M.D., Ph.D, R. Ginsberg, M.D., L. Lewis, M.B.B.Ch., M.-C. Hsu, Ph.D., J. Massarella, Ph.D., M. Molle, RPH, M.A., L. Nerhood, R.N., B. Petty, M.D., S. Reele, M.D., W. Soo, M.D., Ph.D., and S. Tam, Ph.D. The Johns Hopkins University School of Medicine, Division of Clinical Pharmacology, Baltimore,
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
